U.S. President Donald Trump's administration withdrew from the body upon taking office in January, prompting the agency to scale back its work and cut its management team by half.

Medtronic reports stronger-than-expected second-quarter results, fueled by high demand for heart disease and diabetes devices, surpassing profit and revenue forecasts.